REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmazia-r EOOD (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Farmazia-r EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Farmazia-r EOOD is a company in Bulgaria, with a head office in Vidin. The company operates in the Pharmacies and Drug Stores industry. It was first established on 2009. Farmazia-r EOOD currently employs 30 (2023) people. From the latest financial highlights, Farmazia-r EOOD reported a net sales revenue drop of 0.23% in 2022. Over the same period, its total assets grew by 9.53%. In, 2022, the company’s net profit margin decreased by 0.6%.

Headquarters
zh.k. Stefan Stambolov Bl. 3 vh. A et. 1 ap. 1
Vidin; Vidin; Postal Code: 3700

Contact Details: Purchase the Farmazia-r EOOD report to view the information.

Basic Information
Total Employees:
Purchase the Farmazia-r EOOD report to view the information.
Outstanding Shares:
Purchase the Farmazia-r EOOD report to view the information.
Registered Capital:
Purchase the Farmazia-r EOOD report to view the information.
Incorporation Date:
2009
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Farmazia-r EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-0.23%
Total operating revenue
0.02%
Net Profit (Loss) for the Period
-15%
Total assets
9.53%
Total equity
-1.26%
Net Profit Margin
-0.6%
Return on Equity (ROE)
-10.48%
Quick Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?